bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplement Figure 1 from Germline Variants and Advanced Colorectal Adenomas: Adenoma Prevention with Celecoxib Trial Genome-wide Association Study
Authors: Wang Jiping , Carvajal-Carmona Luis G. , Chu Jen-Hwa , Zauber Ann G. , Kubo Michikai , Matsuda Koichi , Dunlop Malcolm , Houlston Richard S. , Sieber Oliver , Lipton Lara , Gibbs Peter , Martin Nicholas G. , Montgomery Grant W. , Young Joanne , Baird Paul N. , Ratain Mark J. , Nakamura Yusuke , Weiss Scott T. , Tomlinson Ian , Bertagnolli Monica M.
Published: April 2023

Supplement Figure 1
Related Article from Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?
Authors: Yee Cassian
Published: April 2023

Related Article from Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?
Supplementary methods and figure legends from Tumor-Reactive CD8+ T Cells in Metastatic Gastrointestinal Cancer Refractory to Chemotherapy
Authors: Turcotte Simon , Gros Alena , Tran Eric , Lee Chyi-Chia R. , Wunderlich John R. , Robbins Paul F. , Rosenberg Steven A.
Published: April 2023

PDF file 136K, Detailed methods for tumor processing, generation of TIL, immunohistochemistry, tumor-recognition assays, and TCR sequencing and cloning. Supplementary Fig. S1 and S2 legends
Supplementary Figure 5 from Activity of the Hypoxia-Activated Prodrug, TH-302, in Preclinical Human Acute Myeloid Leukemia Models
Authors: Portwood Scott , Lal Deepika , Hsu Yung-Chun , Vargas Rodrigo , Johnson Megan K. , Wetzler Meir , Hart Charles P. , Wang Eunice S.
Published: April 2023

PDF file - 120K, Supplemental Figure 5. Effects of hypoxia and drug treatment on ROS generation by AML cells.
Supplementary Methods, Figure Legend, Tables 1 - 6 from Targeting Epithelial-to-Mesenchymal Transition with Met Inhibitors Reverts Chemoresistance in Small Cell Lung Cancer
Authors: Cañadas Israel , Rojo Federico , Taus Álvaro , Arpí Oriol , Arumí-Uría Montserrat , Pijuan Lara , Menéndez Silvia , Zazo Sandra , Dómine Manuel , Salido Marta , Mojal Sergi , García de Herreros Antonio , Rovira Ana , Albanell Joan , Arriola Edurne
Published: April 2023

PDF file - 119K, Supplementary Table 1. Patients� characteristics. Supplementary Table 2. Biomarker expression in human samples. Supplementary Table 3. Spearman correlation between biomarkers� in cases showing expression. Supplementary Table 4. Association of Met and p-Met with other biomarkers. Supplementary Table 5. Cox regression analysis for overall survival for each variable adjusted for performance status (PS) and stage. Supplementary Table 6. Biomarker status in biopsies pre-treatment and at relapsed disease.
Supplementary Materials and Methods and Figure Legends from A Poor Prognosis Subtype of HNSCC Is Consistently Observed across Methylome, Transcriptome, and miRNome Analysis
Authors: Jung Alain C. , Job Sylvie , Ledrappier Sonia , Macabre Christine , Abecassis Joseph , de Reyniès Aurélien , Wasylyk Bohdan
Published: April 2023

Supplementary Materials and Methods and Figure Legends - PDF file 192K, This file contains the Supplementary Material and Methods and the legends to the Supplementary Figures S1-S8
Supplementary Table 4 from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
Authors: Shapiro Geoffrey I. , Rodon Jordi , Bedell Cynthia , Kwak Eunice L. , Baselga Jose , Braña Irene , Pandya Shuchi S. , Scheffold Christian , Laird A. Douglas , Nguyen Linh T. , Xu Yi , Egile Coumaran , Edelman Gerald
Published: April 2023

PDF file - 91K, Anti-tumor activity in patients receiving treatment more than 16 weeks.
Supplementary Legend from Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008
Authors: Burvenich Ingrid J.G. , Lee Fook T. , Cartwright Glenn A. , O'Keefe Graeme J. , Makris Dahna , Cao Diana , Gong Sylvia , Chueh Anderly C. , Mariadason John M. , Brechbiel Martin W. , Beckman Robert A. , Fujiwara Kosaku , von Roemeling Reinhard , Scott Andrew M.
Published: April 2023

Supplementary Legend - PDF file 77K, Supplementary legend
Supplementary Figure Legends from Phase I Safety, Pharmacokinetic, and Pharmacodynamic Study of SAR245408 (XL147), an Oral Pan-Class I PI3K Inhibitor, in Patients with Advanced Solid Tumors
Authors: Shapiro Geoffrey I. , Rodon Jordi , Bedell Cynthia , Kwak Eunice L. , Baselga Jose , Braña Irene , Pandya Shuchi S. , Scheffold Christian , Laird A. Douglas , Nguyen Linh T. , Xu Yi , Egile Coumaran , Edelman Gerald
Published: April 2023

PDF file - 74K
Supplementary Figure S1 from Molecular Imaging of Death Receptor 5 Occupancy and Saturation Kinetics In Vivo by Humanized Monoclonal Antibody CS-1008
Authors: Burvenich Ingrid J.G. , Lee Fook T. , Cartwright Glenn A. , O'Keefe Graeme J. , Makris Dahna , Cao Diana , Gong Sylvia , Chueh Anderly C. , Mariadason John M. , Brechbiel Martin W. , Beckman Robert A. , Fujiwara Kosaku , von Roemeling Reinhard , Scott Andrew M.
Published: April 2023

Supplementary Figure S1 - PDF file 63K, Planar gamma camera imaging with 111In-CHX-A"-DTPA-CS-1008 in mice bearing CT26 tumors (A, B) or COLO 205 tumors (C, D) at seven days post injection. Arrows indicate the location of the tumors
Supplementary Figure 2 from Comparison of Statistical Analysis Plans in Randomize-All Phase III Trials with a Predictive Biomarker
Authors: Matsui Shigeyuki , Choai Yuki , Nonaka Takahiro
Published: April 2023

PDF file - 62KB, P overall, P subset, and P success, for various numbers of events, E, under a qualitative interaction (HR+, HR−) = (0.5, 1.0).
Supplementary Figure 1 from Overexpression of the Circadian Clock Gene Bmal1 Increases Sensitivity to Oxaliplatin in Colorectal Cancer
Authors: Zeng Zhao-lei , Luo Hui-yan , Yang Jing , Wu Wen-jing , Chen Dong-liang , Huang Peng , Xu Rui-hua
Published: April 2023

PDF file 18K, Bmal1 overexpression in the HCT116 and THC8307 cells after 30 generations of cell culture
Supplementary Table 5 from Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Authors: Wik Elisabeth , Ræder Maria B. , Krakstad Camilla , Trovik Jone , Birkeland Even , Hoivik Erling A. , Mjos Siv , Werner Henrica M.J. , Mannelqvist Monica , Stefansson Ingunn M. , Oyan Anne M. , Kalland Karl H. , Akslen Lars A. , Salvesen Helga B.
Published: April 2023

PDF file - 132 KB, Selection of single genes (Tab A) and transcription factor gene sets (Tab B) differentially expressed between ER� negative and ER� positive endometrial carcinomas (primary investigation set).
Supplementary Tables 1 - 4 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Authors: Silwal-Pandit Laxmi , Vollan Hans Kristian Moen , Chin Suet-Feung , Rueda Oscar M. , McKinney Steven , Osako Tomo , Quigley David A. , Kristensen Vessela N. , Aparicio Samuel , Børresen-Dale Anne-Lise , Caldas Carlos , Langerød Anita
Published: April 2023

XLSX file - 94KB, Table S1 TP53 mutation status, TP53 IHC staining and lymphocyte infiltration. Table S2 Univariate Cox regression analysis (BCSS). Table S3 Multivariate Cox regression analysis (BCSS). Table S4 Multivariate Cox regression analysis (OS).
Supplementary Table 3 from Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Authors: Wik Elisabeth , Ræder Maria B. , Krakstad Camilla , Trovik Jone , Birkeland Even , Hoivik Erling A. , Mjos Siv , Werner Henrica M.J. , Mannelqvist Monica , Stefansson Ingunn M. , Oyan Anne M. , Kalland Karl H. , Akslen Lars A. , Salvesen Helga B.
Published: April 2023

PDF file - 69 KB, Comparing clinic-pathologic data in the different cohorts; the primary investigation series, prospective validation series and the external microarray data set are compared to the retrospective population based series.
Supplementary Figure 8 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Authors: Silwal-Pandit Laxmi , Vollan Hans Kristian Moen , Chin Suet-Feung , Rueda Oscar M. , McKinney Steven , Osako Tomo , Quigley David A. , Kristensen Vessela N. , Aparicio Samuel , Børresen-Dale Anne-Lise , Caldas Carlos , Langerød Anita
Published: April 2023

PDF file - 40KB, Figure S8. A. Frequency of TP53 mutations and LOH in PAM50 and IC subtypes. B. Kaplan-Meier survival curves showing BCSS of TP53 mutation status in combination with LOH and MDM2 amplification. C. BCSS of TP53 mutation status combined with lymphocyte infiltration in ER negative patients. Numbers at risk are listed below each chart e = no. of all deaths (OS) or Breast Cancer specific deaths (BCSS).
Supplementary Figure 2 from Lack of Estrogen Receptor-α Is Associated with Epithelial–Mesenchymal Transition and PI3K Alterations in Endometrial Carcinoma
Authors: Wik Elisabeth , Ræder Maria B. , Krakstad Camilla , Trovik Jone , Birkeland Even , Hoivik Erling A. , Mjos Siv , Werner Henrica M.J. , Mannelqvist Monica , Stefansson Ingunn M. , Oyan Anne M. , Kalland Karl H. , Akslen Lars A. , Salvesen Helga B.
Published: April 2023

PDF file - 43 KB, Clustering of transcriptional data in relation to ER� and ESR1 expression
Supplementary Figure 2 from TP53 Mutation Spectrum in Breast Cancer Is Subtype Specific and Has Distinct Prognostic Relevance
Authors: Silwal-Pandit Laxmi , Vollan Hans Kristian Moen , Chin Suet-Feung , Rueda Oscar M. , McKinney Steven , Osako Tomo , Quigley David A. , Kristensen Vessela N. , Aparicio Samuel , Børresen-Dale Anne-Lise , Caldas Carlos , Langerød Anita
Published: April 2023

PDF file - 26KB, Figure S2. Distribution of TP53 mutation class in breast cancer subtypes. A. PAM50 and B. IC subtypes.
Supplementary Figures 1-7 from Breast Cancer Index Identifies Early-Stage Estrogen Receptor–Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
Authors: Zhang Yi , Schnabel Catherine A. , Schroeder Brock E. , Jerevall Piiha-Lotta , Jankowitz Rachel C. , Fornander Tommy , Stål Olle , Brufsky Adam M. , Sgroi Dennis , Erlander Mark G.
Published: April 2023

Supplementary Figures 1-7 - PDF file 117K, Supplementary Figure 1. Cohorts used for BCI model training and validation Supplementary Figure 2. Performance of H:I and MGI for early (0-5 years) and late (> 5 years) distant recurrence in Stockholm ER+, LN- untreated patients. A, C: H:I, 0-5 years and > 5 years. B, D: MGI, 0-5 years and > 5 years. Supplementary Figure 3. BCI risk groups for prediction of overall distant recurrence in Stockholm TAM and Multi-institutional cohorts, ER+, LN- patients. Supplementary Figure 4. Continuous BCI score for overall (0 - 10 years) rate of distant recurrence in Stockholm TAM cohort. Supplementary Figure 5. BCI risk groups for prediction of early and late distant recurrence in the combined StockholmTAM and Multi-institutional cohort; ER+, LN-, tamoxifen-treated patients. Supplementary Figure 6. Continuous BCI score for early (0 - 5 years) and late (> 5 years) rate of distant recurrence in the combined Stockholm TAM and Multi-institutional cohort (ER+, LN-, tamoxifen-treated patients). Supplementary Figure 7. Prediction of tamoxifen benefit by H/I. A: no benefit of tamoxifen in H/I-low patients. B: benefit of tamoxifen in H/I-high patients
Supplementary Figure Legend from Quantification of Excision Repair Cross-Complementing Group 1 and Survival in p16-Negative Squamous Cell Head and Neck Cancers
Authors: Mehra Ranee , Zhu Fang , Yang Dong-Hua , Cai Kathy Q. , Weaver JoEllen , Singh Mahendra K. , Nikonova Anna S. , Golemis Erica A. , Flieder Douglas B. , Cooper Harry S. , Lango Miriam , Ridge John A. , Burtness Barbara
Published: April 2023

PDF file - 56K
Supplementary Table 3 from LINE-1 Hypomethylation, DNA Copy Number Alterations, and CDK6 Amplification in Esophageal Squamous Cell Carcinoma
Authors: Baba Yoshifumi , Watanabe Masayuki , Murata Asuka , Shigaki Hironobu , Miyake Keisuke , Ishimoto Takatsugu , Iwatsuki Masaaki , Iwagami Shiro , Yoshida Naoya , Oki Eiji , Sakamaki Kentaro , Nakao Mitsuyoshi , Baba Hideo
Published: April 2023

PDF file - 56K, LINE-1 methylation level in 129 esophageal cancers, and the association with the clinical and tumor features.
Supplementary Table 1 from Quantitative ER and PgR Assessment as Predictors of Benefit from Lapatinib in Postmenopausal Women with Hormone Receptor–Positive, HER2-Negative Metastatic Breast Cancer
Authors: Finn Richard S. , Press Michael F. , Dering Judy , O'Rourke Lisa , Florance Allison , Ellis Catherine , Martin Anne-Marie , Johnston Stephen
Published: April 2023

PDF - 66K, This table contains the clinical characterisitcs of patients enrolled in the EGF 30008 trial.
Supplementary Figure Legend from Topotecan and Doxorubicin Combination to Treat Recurrent Ovarian Cancer: The Influence of Drug Exposure Time and Delivery Systems to Achieve Optimum Therapeutic Activity
Authors: Patankar Nilesh A. , Pritchard Julia , van Grinsven Mariska , Osooly Maryam , Bally Marcel B.
Published: April 2023

PDF file - 55 KB
Supplementary Table 1 from In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
Authors: Schalper Kurt A. , Velcheti Vamsidhar , Carvajal Daniel , Wimberly Hallie , Brown Jason , Pusztai Lajos , Rimm David L.
Published: April 2023

XLSX file - 13K, Clinico-pathological characteristics of YTMA128 and 201.
Supplementary Methods from In Situ Tumor PD-L1 mRNA Expression Is Associated with Increased TILs and Better Outcome in Breast Carcinomas
Authors: Schalper Kurt A. , Velcheti Vamsidhar , Carvajal Daniel , Wimberly Hallie , Brown Jason , Pusztai Lajos , Rimm David L.
Published: April 2023

PDF file - 73K
upplementary Figure 3 from Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Authors: John Liza B. , Devaud Christel , Duong Connie P.M. , Yong Carmen S. , Beavis Paul A. , Haynes Nicole M. , Chow Melvyn T. , Smyth Mark J. , Kershaw Michael H. , Darcy Phillip K.
Published: April 2023

upplementary Figure 3 - PDF file 17K, Gr1+ cells express PD-1 and PD-L1
Supplementary Figure 1 from Downregulation of miR-138 Sustains NF-κB Activation and Promotes Lipid Raft Formation in Esophageal Squamous Cell Carcinoma
Authors: Gong Hui , Song Libing , Lin Chuyong , Liu Aibin , Lin Xi , Wu Jueheng , Li Mengfeng , Li Jun
Published: April 2023

PDF file - 25 KB, miR-138 expression is downregulated in ESCC.
Supplementary Figure Legends from Targeted Imaging of Ewing Sarcoma in Preclinical Models Using a 64Cu-Labeled Anti-CD99 Antibody
Authors: O'Neill Allison F. , Dearling Jason L.J. , Wang Yuchuan , Tupper Tanya , Sun Yanping , Aster Jon C. , Calicchio Monica L. , Perez-Atayde Antonio R. , Packard Alan B. , Kung Andrew L.
Published: April 2023

PDF file 17K, Supplementary Figure 1: Staining of additional Ewing sarcoma cell lines. All Ewing sarcoma cell lines tested stain equivalently positive for DN16. In all panels, unstained and isotype matched IgG are controls. Supplementary Figure 2: MRI detection of experimental metastases. Experimental liver metastases were induced by IV injection of TC32 cells. Imaging with a 7T MRI demonstrates 1-2 mm metastatic lesions in the liver (white arrows) -
Supplementary Figure 1 from mTORC1 Inhibitors Suppress Meningioma Growth in Mouse Models
Authors: Pachow Doreen , Andrae Nadine , Kliese Nadine , Angenstein Frank , Stork Oliver , Wilisch-Neumann Annette , Kirches Elmar , Mawrin Christian
Published: April 2023

PDF file - 69K, Real time-PCR primer sequences
Supplementary Figure S3 from Distinction between Asymptomatic Monoclonal B-cell Lymphocytosis with Cyclin D1 Overexpression and Mantle Cell Lymphoma: From Molecular Profiling to Flow Cytometry
Authors: Espinet Blanca , Ferrer Ana , Bellosillo Beatriz , Nonell Lara , Salar Antonio , Fernández-Rodríguez Concepción , Puigdecanet Eulàlia , Gimeno Javier , Garcia-Garcia Mar , Vela Maria Carmen , Luño Elisa , Collado Rosa , Navarro José Tomás , de la Banda Esmeralda , Abrisqueta Pau , Arenillas Leonor , Serrano Cristina , Lloreta Josep , Miñana Belén , Cerutti Andrea , Florensa Lourdes , Orfao Alberto , Sanz Ferran , Solé Francesc , Dominguez-Sola David , Serrano Sergio
Published: April 2023

PDF file 231K, Differences in SOX11 mRNA levels, exon usage and protein expression between MALD1 and MCL cases
Supplementary Figure 8 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Authors: Salvador Marion A. , Wicinski Julien , Cabaud Olivier , Toiron Yves , Finetti Pascal , Josselin Emmanuelle , Lelièvre Hélène , Kraus-Berthier Laurence , Depil Stéphane , Bertucci François , Collette Yves , Birnbaum Daniel , Charafe-Jauffret Emmanuelle , Ginestier Christophe
Published: April 2023

PDF file 35K, Expression level of Xist in patient-derived xenograft
Supplementary Figure 7 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Authors: Salvador Marion A. , Wicinski Julien , Cabaud Olivier , Toiron Yves , Finetti Pascal , Josselin Emmanuelle , Lelièvre Hélène , Kraus-Berthier Laurence , Depil Stéphane , Bertucci François , Collette Yves , Birnbaum Daniel , Charafe-Jauffret Emmanuelle , Ginestier Christophe
Published: April 2023

PDF file 126K, The effect of abexinostat on CSC is achieved through the specific inhibition of HDACs
Supplementary Figure 4 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Authors: Salvador Marion A. , Wicinski Julien , Cabaud Olivier , Toiron Yves , Finetti Pascal , Josselin Emmanuelle , Lelièvre Hélène , Kraus-Berthier Laurence , Depil Stéphane , Bertucci François , Collette Yves , Birnbaum Daniel , Charafe-Jauffret Emmanuelle , Ginestier Christophe
Published: April 2023

PDF file 123K, HDAC activity is impaired by treatment independently of drugresponse profiles
CCR Translation for This Article from Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth
Authors: Grohar Patrick J. , Segars Laure E. , Yeung Choh , Pommier Yves , D'Incalci Maurizio , Mendoza Arnulfo , Helman Lee J.
Published: April 2023

CCR Translation for This Article from Dual Targeting of EWS-FLI1 Activity and the Associated DNA Damage Response with Trabectedin and SN38 Synergistically Inhibits Ewing Sarcoma Cell Growth
Supplementary Table 4 from Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib–Rituximab Versus Rituximab
Authors: Coiffier Bertrand , Li Weimin , Henitz Erin D. , Karkera Jayaprakash D. , Favis Reyna , Gaffney Dana , Shapiro Alice , Theocharous Panteli , Elsayed Yusri A. , van de Velde Helgi , Schaffer Michael E. , Osmanov Evgenii A. , Hong Xiaonan , Scheliga Adriana , Mayer Jiri , Offner Fritz , Rule Simon , Teixeira Adriana , Romejko-Jarosinska Joanna , de Vos Sven , Crump Michael , Shpilberg Ofer , Zinzani Pier Luigi , Cakana Andrew , Esseltine Dixie-Lee , Mulligan George , Ricci Deborah
Published: April 2023

Supplementary Table 4 PDF file 69K, OS, ORR, CR rate, and TTNT in all patients in the cross-validation model (see Supplementary Methods) who were positive or negative for the biomarker pair PSMB1 P11A (G allele) and low CD68 expression (≤50 CD68-positive cells). Among all biomarker-positive patients there was a significantly longer OS with bortezomib-rituximab versus rituximab, a significantly higher ORR, a higher CR rate, and a significantly longer TTNT. No significant differences were seen for biomarker-negative patients
Supplementary Figure 2 from The Histone Deacetylase Inhibitor Abexinostat Induces Cancer Stem Cells Differentiation in Breast Cancer with Low Xist Expression
Authors: Salvador Marion A. , Wicinski Julien , Cabaud Olivier , Toiron Yves , Finetti Pascal , Josselin Emmanuelle , Lelièvre Hélène , Kraus-Berthier Laurence , Depil Stéphane , Bertucci François , Collette Yves , Birnbaum Daniel , Charafe-Jauffret Emmanuelle , Ginestier Christophe
Published: April 2023

PDF file 192K, HDACi treatments define two drug-response profiles in BCLs
Supplementary Table 1 from Prespecified Candidate Biomarkers Identify Follicular Lymphoma Patients Who Achieved Longer Progression-Free Survival with Bortezomib–Rituximab Versus Rituximab
Authors: Coiffier Bertrand , Li Weimin , Henitz Erin D. , Karkera Jayaprakash D. , Favis Reyna , Gaffney Dana , Shapiro Alice , Theocharous Panteli , Elsayed Yusri A. , van de Velde Helgi , Schaffer Michael E. , Osmanov Evgenii A. , Hong Xiaonan , Scheliga Adriana , Mayer Jiri , Offner Fritz , Rule Simon , Teixeira Adriana , Romejko-Jarosinska Joanna , de Vos Sven , Crump Michael , Shpilberg Ofer , Zinzani Pier Luigi , Cakana Andrew , Esseltine Dixie-Lee , Mulligan George , Ricci Deborah
Published: April 2023

Supplementary Table 1 PDF file 55K, Cut-points for protein markers used in different analyses. Cut-points selected for pair-wise comparisons were chosen to reduce the total number of comparisons that would be done. Cut-points for the discovery/confirmation analyses (see Supplementary Methods) were optimized based on enrichment of responders versus non-responders and reasonable population size
Supplementary Figure Legend from Inhibition of Tumor Growth and Metastasis in Non–Small Cell Lung Cancer by LY2801653, an Inhibitor of Several Oncokinases, Including MET
Authors: Wu Wenjuan , Bi Chen , Credille Kelly M. , Manro Jason R. , Peek Victoria L. , Donoho Gregory P. , Yan Lei , Wijsman John A. , Yan S. Betty , Walgren Richard A.
Published: April 2023

Supplementary Figure Legend - PDF file 70K, Supplementary Figure Legend
Table S2 from miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Authors: Tang Hailin , Deng Min , Tang Yunyun , Xie Xinhua , Guo Jiaoli , Kong Yanan , Ye Feng , Su Qi , Xie Xiaoming
Published: April 2023

Table S2 - PDF file 66K, Univariate and multivariable Cox regression analysis of overall survival (Cox proportional hazards regression model)
Table S1 from miR-200b and miR-200c as Prognostic Factors and Mediators of Gastric Cancer Cell Progression
Authors: Tang Hailin , Deng Min , Tang Yunyun , Xie Xinhua , Guo Jiaoli , Kong Yanan , Ye Feng , Su Qi , Xie Xiaoming
Published: April 2023

Table S1 - PDF file 47K, miR-200b and miR-200c is downregulated in primary gastric cancer
CCR Translation for This Article from Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy
Authors: Phillips Gail D. Lewis , Fields Carter T. , Li Guangmin , Dowbenko Donald , Schaefer Gabriele , Miller Kathy , Andre Fabrice , Burris Howard A. , Albain Kathy S. , Harbeck Nadia , Dieras Veronique , Crivellari Diana , Fang Liang , Guardino Ellie , Olsen Steven R. , Crocker Lisa M. , Sliwkowski Mark X.
Published: April 2023

CCR Translation for This Article from Dual Targeting of HER2-Positive Cancer with Trastuzumab Emtansine and Pertuzumab: Critical Role for Neuregulin Blockade in Antitumor Response to Combination Therapy
Supplementary Figure 7 from AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
Authors: Dunne Philip D. , McArt Darragh G. , Blayney Jaine K. , Kalimutho Murugan , Greer Samanda , Wang Tingting , Srivastava Supriya , Ong Chee Wee , Arthur Ken , Loughrey Maurice , Redmond Keara , Longley Daniel B. , Salto-Tellez Manuel , Johnston Patrick G. , Van Schaeybroeck Sandra
Published: April 2023

PDF file - 94K, Sensitivity of parental and invasive CRC cells to chemotherapy and EGFR targeted therapies.
Supplementary Figure 1 from AXL Is a Key Regulator of Inherent and Chemotherapy-Induced Invasion and Predicts a Poor Clinical Outcome in Early-Stage Colon Cancer
Authors: Dunne Philip D. , McArt Darragh G. , Blayney Jaine K. , Kalimutho Murugan , Greer Samanda , Wang Tingting , Srivastava Supriya , Ong Chee Wee , Arthur Ken , Loughrey Maurice , Redmond Keara , Longley Daniel B. , Salto-Tellez Manuel , Johnston Patrick G. , Van Schaeybroeck Sandra
Published: April 2023

PDF file - 138K, Experimental overview for generation and characterization of invasive CRC subclones.
Supplementary Figure 4 from Personalized Chemotherapy Profiling Using Cancer Cell Lines from Selectable Mice
Authors: Kamiyama Hirohiko , Rauenzahn Sherri , Shim Joong Sup , Karikari Collins A. , Feldmann Georg , Hua Li , Kamiyama Mihoko , Schuler F. William , Lin Ming-Tseh , Beaty Robert M. , Karanam Balasubramanyam , Liang Hong , Mullendore Michael E. , Mo Guanglan , Hidalgo Manuel , Jaffee Elizabeth , Hruban Ralph H. , Jinnah H.A. , Roden Richard B.S. , Jimeno Antonio , Liu Jun O. , Maitra Anirban , Eshleman James R.
Published: April 2023

PDF file - 1505K, Selection of pancreatic cancer cell line, Panc502.
Supplementary Figure 6 from Regulation of Cell Proliferation and Migration by Keratin19-Induced Nuclear Import of Early Growth Response-1 in Breast Cancer Cells
Authors: Ju Ji-hyun , Yang Wonseok , Lee Kyung-min , Oh Sunhwa , Nam KeeSoo , Shim Sarah , Shin Soon Young , Gye Myung Chan , Chu In-Sun , Shin Incheol
Published: April 2023

Supplementary Figure 6 - PDF file 1339K, Statistical analyses of western blots and RT-PCR data
Supplementary Information from Association of TP53 Mutational Status and Gender with Survival after Adjuvant Treatment for Stage III Colon Cancer: Results of CALGB 89803
Authors: Warren Robert S. , Atreya Chloe E. , Niedzwiecki Donna , Weinberg Vivian K. , Donner David B. , Mayer Robert J. , Goldberg Richard M. , Compton Carolyn C. , Zuraek Marlene B. , Ye Cynthia , Saltz Leonard B. , Bertagnolli Monica M.
Published: April 2023

Supplementary Information - PDF file 170K, methods for sequencing of TP53; ii) Table S1 giving the clinical and pathologic features of all patients enrolled in CALGB 89803 and the subset of patients in the current study as a function of TP53 genotype; iii) Table S2 giving the results of an exploratory analysis of DFS and OS as a function of treatment arm, TP53 genotype and gender; iv) Table S3 showing results of a multivariable analysis for DFS and OS with the following variables retained from a univariate analysis: sex,TP53 genotype, sex by TP53 genotype interaction, as well as pathologic variables; v) Supplementary Figure Legends
Supplementary Fig. 3 from Regulation of Cell Proliferation and Migration by Keratin19-Induced Nuclear Import of Early Growth Response-1 in Breast Cancer Cells
Authors: Ju Ji-hyun , Yang Wonseok , Lee Kyung-min , Oh Sunhwa , Nam KeeSoo , Shim Sarah , Shin Soon Young , Gye Myung Chan , Chu In-Sun , Shin Incheol
Published: April 2023

Supplementary Fig. 3 - PDF file 2033K, KRT19 inhibition induces Akt activity through down-regulation of PTEN expression.
Supplementary Figure 5 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas
Authors: Gini Beatrice , Zanca Ciro , Guo Deliang , Matsutani Tomoo , Masui Kenta , Ikegami Shiro , Yang Huijun , Nathanson David , Villa Genaro R. , Shackelford David , Zhu Shaojun , Tanaka Kazuhiro , Babic Ivan , Akhavan David , Lin Kelly , Assuncao Alvaro , Gu Yuchao , Bonetti Bruno , Mortensen Deborah S. , Xu Shuichan , Raymon Heather K. , Cavenee Webster K. , Furnari Frank B. , James C. David , Kroemer Guido , Heath James R. , Hege Kristen , Chopra Rajesh , Cloughesy Timothy F. , Mischel Paul S.
Published: April 2023

PDF file - 2080K, Tunable expression of EGFRvIII in genetically modified models correlates with autophagy induction upon CC214-1 treatment.
Supplementary Figure 3 from The mTOR Kinase Inhibitors, CC214-1 and CC214-2, Preferentially Block the Growth of EGFRvIII-Activated Glioblastomas
Authors: Gini Beatrice , Zanca Ciro , Guo Deliang , Matsutani Tomoo , Masui Kenta , Ikegami Shiro , Yang Huijun , Nathanson David , Villa Genaro R. , Shackelford David , Zhu Shaojun , Tanaka Kazuhiro , Babic Ivan , Akhavan David , Lin Kelly , Assuncao Alvaro , Gu Yuchao , Bonetti Bruno , Mortensen Deborah S. , Xu Shuichan , Raymon Heather K. , Cavenee Webster K. , Furnari Frank B. , James C. David , Kroemer Guido , Heath James R. , Hege Kristen , Chopra Rajesh , Cloughesy Timothy F. , Mischel Paul S.
Published: April 2023

PDF file - 1554K, Cap-dependent translation is enhanced by EGFRvIII expression and CC214-1 strongly inhibits P-4E-BP1 phosphorylation.
Supplementary Table 3 from Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Authors: Remark Romain , Alifano Marco , Cremer Isabelle , Lupo Audrey , Dieu-Nosjean Marie-Caroline , Riquet Marc , Crozet Lucile , Ouakrim Hanane , Goc Jeremy , Cazes Aurélie , Fléjou Jean-François , Gibault Laure , Verkarre Virginie , Régnard Jean-François , Pagès Olivier-Nicolas , Oudard Stéphane , Mlecnik Bernhard , Sautès-Fridman Catherine , Fridman Wolf-Herman , Damotte Diane
Published: April 2023

PDF file - 56K, P values corresponding to different cutoff (minimum P value, first, second and third quartile) in CRC and RCC lung metastases. {section sign}P values were corrected by the formula proposed by Altman et al.
Supplementary Figure 3 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer
Authors: Yu Hongyan , Ye Wen , Wu Jiangxue , Meng Xiangqi , Liu Ran-yi , Ying Xiaofang , Zhou Yi , Wang Hui , Pan Changchuan , Huang Wenlin
Published: April 2023

PDF file - 2323KB, Effect of Sirt7 on CRC cell growth and metastasis in vivo. (A) Mice were injected subcutaneously with cells (105 cells/mouse). Tumor weight were measured after mice were euthanised, plotted as the mean� SEM. The left panel displays tumor growth in nude mice injected with the two groups of cells (Sirt7-HT29 and ctrl-HT29). (B) representative meastatic nodules on the surface of the skin of nude mmice indicated by arrows).
Supplementary Figure 3 from Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Authors: Remark Romain , Alifano Marco , Cremer Isabelle , Lupo Audrey , Dieu-Nosjean Marie-Caroline , Riquet Marc , Crozet Lucile , Ouakrim Hanane , Goc Jeremy , Cazes Aurélie , Fléjou Jean-François , Gibault Laure , Verkarre Virginie , Régnard Jean-François , Pagès Olivier-Nicolas , Oudard Stéphane , Mlecnik Bernhard , Sautès-Fridman Catherine , Fridman Wolf-Herman , Damotte Diane
Published: April 2023

PDF file - 101K, Influence of pre-operative patient treatments on the distribution of CD8+, DC-LAMP+ and NKp46+ immune cells in CRC (a, b and c) and RCC lung metastases (d, e and f). 63/140 patients with CRC lung metastases have been treated with neo-adjuvant chemotherapy and 9/52 patients with RCC lung metastases have been treated with IL2/IFN. Whiskers length represents 10-90 percentile. ns, not significant (Mann-Whitney test).
Supplementary Figure 2 from Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Authors: Remark Romain , Alifano Marco , Cremer Isabelle , Lupo Audrey , Dieu-Nosjean Marie-Caroline , Riquet Marc , Crozet Lucile , Ouakrim Hanane , Goc Jeremy , Cazes Aurélie , Fléjou Jean-François , Gibault Laure , Verkarre Virginie , Régnard Jean-François , Pagès Olivier-Nicolas , Oudard Stéphane , Mlecnik Bernhard , Sautès-Fridman Catherine , Fridman Wolf-Herman , Damotte Diane
Published: April 2023

PDF file - 148K, Kaplan-Meier curves for the duration of OS according to the presence of CD8+ T cells in the center of the tumor (CT) (a), in the invasive margin (IM) (b) and in combined regions (CT+IM) (c) of RCC lung metastases. Representation of the Kaplan-Meier curves for the duration of OS according to the presence of NKp46+ cells in the CT (d), in the IM (e) and in combined region (CT+IM) (f) of RCC lung metastases. Statistical comparison was performed by the log-rank test.
Supplementary Figure 1 from Overexpression of Sirt7 Exhibits Oncogenic Property and Serves as a Prognostic Factor in Colorectal Cancer
Authors: Yu Hongyan , Ye Wen , Wu Jiangxue , Meng Xiangqi , Liu Ran-yi , Ying Xiaofang , Zhou Yi , Wang Hui , Pan Changchuan , Huang Wenlin
Published: April 2023

PDF file - 285KB, The expression of Sirt7 protein in colorectal cancer sections. Representative immunohistochemical images of colorectal cancer tissue specimens indicating negative or weakly detectable Sirt7 staining (A and B), moderate Sirt7 staining (C), and strong Sirt7 staining (D) are shown. Magnification is x 200 (A, B, C and D).
Supplementary Figure 1 from Characteristics and Clinical Impacts of the Immune Environments in Colorectal and Renal Cell Carcinoma Lung Metastases: Influence of Tumor Origin
Authors: Remark Romain , Alifano Marco , Cremer Isabelle , Lupo Audrey , Dieu-Nosjean Marie-Caroline , Riquet Marc , Crozet Lucile , Ouakrim Hanane , Goc Jeremy , Cazes Aurélie , Fléjou Jean-François , Gibault Laure , Verkarre Virginie , Régnard Jean-François , Pagès Olivier-Nicolas , Oudard Stéphane , Mlecnik Bernhard , Sautès-Fridman Catherine , Fridman Wolf-Herman , Damotte Diane
Published: April 2023

PDF file - 107K, Kaplan-Meier curves for the duration of OS according to the presence of CD8+ T cells in the center of the tumor (CT) (a), in the invasive margin (IM) (b) and in combined regions (CT+IM) (c) of CRC lung metastases. Statistical comparison was performed by the log-rank test.
Supplementary Methods from Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Authors: Govindaraj Chindu , Tan Peter , Walker Patricia , Wei Andrew , Spencer Andrew , Plebanski Magdalena
Published: April 2023

PDF file - 98K, Methods for in vitro depletion assays and in vitro induction assays using TNF.
Supplementary Figure 6 from Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Authors: Govindaraj Chindu , Tan Peter , Walker Patricia , Wei Andrew , Spencer Andrew , Plebanski Magdalena
Published: April 2023

PDF file - 2213K, The effect of treatment drugs on TNFR2, CD25 and FOXP3 expression as well as on intracellular cytokine production.
Supplementary Tables from Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
Authors: Li Lei , Du Yiqi , Kong Xiangyu , Li Zhaoshen , Jia Zhiliang , Cui Jiujie , Gao Jun , Wang Guokun , Xie Keping
Published: April 2023

Supplementary Tables - PDF file 192K, Supplementary Table S1 Genes Supplementary Table S2 Patient characteristics and lamin B1 expression Supplementary Table S3 Multivariate COX regression analysis of overall survival in relation to clinicopathologic features and lamin B1 expression
Supplementary Figures from Lamin B1 Is a Novel Therapeutic Target of Betulinic Acid in Pancreatic Cancer
Authors: Li Lei , Du Yiqi , Kong Xiangyu , Li Zhaoshen , Jia Zhiliang , Cui Jiujie , Gao Jun , Wang Guokun , Xie Keping
Published: April 2023

Supplementary Figures - PDF file 584K, Supplementary Figures contain 5 figures: Supplementary Fig. S1. Gene expression profiling in pancreatic cancer cells treated with BA. Supplementary Fig. S2. Inhibition of the in vitro and in vivo growth of primary pancreatic cancer cultures and xenografts. Supplementary Fig. S3. Lamin B1 expression pattern in pancreatic tissue. Supplementary Fig. S4. Lamin B1 expression on the nuclear envelop from nuclei with different sizes. Supplementary Fig. S5. Altered lamin B1 expression affect cell cycle progression of pancreatic cancer cells
Supplementary Figure 2 from Reducing TNF Receptor 2+ Regulatory T Cells via the Combined Action of Azacitidine and the HDAC Inhibitor, Panobinostat for Clinical Benefit in Acute Myeloid Leukemia Patients
Authors: Govindaraj Chindu , Tan Peter , Walker Patricia , Wei Andrew , Spencer Andrew , Plebanski Magdalena
Published: April 2023

PDF file - 1614K, TNFR2+ Tregs are potent regulatory T cells.
Supplementary Table 3 from High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition
Authors: Wik Elisabeth , Birkeland Even , Trovik Jone , Werner Henrica M.J. , Hoivik Erling A. , Mjos Siv , Krakstad Camilla , Kusonmano Kanthida , Mauland Karen , Stefansson Ingunn M. , Holst Frederik , Petersen Kjell , Oyan Anne M. , Simon Ronald , Kalland Karl H. , Ricketts William , Akslen Lars A. , Salvesen Helga B.
Published: April 2023

PDF file - 84K, Gene Set Enrichment Analysis (www.broadinstitute.org/gsea/msigdb). Gene sets (GO categories, computational gene sets and curated gene sets) within FDR<10% related to cell cycle/cell proliferation and being enriched in tumors with high level of pStathmin(S38).
Supplementary Table 1 from Trial Designs for Personalizing Cancer Care: A Systematic Review and Classification
Authors: Tajik Parvin , Zwinderman Aleiko H. , Mol Ben W. , Bossuyt Patrick M.
Published: April 2023

PDF file - 23K, Selected articles.
Supplementary Table S4 from Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer
Authors: Iwaya Takeshi , Fukagawa Takeo , Suzuki Yutaka , Takahashi Yusuke , Sawada Genta , Ishibashi Masahisa , Kurashige Junji , Sudo Tomoya , Tanaka Fumiaki , Shibata Kohei , Endo Fumitaka , Katagiri Hirokatsu , Ishida Kaoru , Kume Kohei , Nishizuka Satoshi , Iinuma Hisae , Wakabayashi Go , Mori Masaki , Sasako Mitsuru , Mimori Koshi
Published: April 2023

XLS file 26K, Genes with higher expression in the BM from Stage IV patients compared to that from Stage I patients
Supplementary Figure 1 from Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer
Authors: Barnett Christine M. , Heinrich Michael C. , Lim Jeong , Nelson Dylan , Beadling Carol , Warrick Andrea , Neff Tanaya , Higano Celestia S. , Garzotto Mark , Qian David , Corless Christopher L. , Thomas George V. , Beer Tomasz M.
Published: April 2023

PDF file 374K, Supplementary Figure 1. Validation of PTEN immunohistochemistry
Appendix from Genetic Profiling to Determine Risk of Relapse-Free Survival in High-Risk Localized Prostate Cancer
Authors: Barnett Christine M. , Heinrich Michael C. , Lim Jeong , Nelson Dylan , Beadling Carol , Warrick Andrea , Neff Tanaya , Higano Celestia S. , Garzotto Mark , Qian David , Corless Christopher L. , Thomas George V. , Beer Tomasz M.
Published: April 2023

PDF file 41K, Appendix: Detailed Sequencing information for the solid tumor Sequenom panel
Supplementary Table S1 from Contrasting Expression Patterns of Histone mRNA and microRNA 760 in Patients with Gastric Cancer
Authors: Iwaya Takeshi , Fukagawa Takeo , Suzuki Yutaka , Takahashi Yusuke , Sawada Genta , Ishibashi Masahisa , Kurashige Junji , Sudo Tomoya , Tanaka Fumiaki , Shibata Kohei , Endo Fumitaka , Katagiri Hirokatsu , Ishida Kaoru , Kume Kohei , Nishizuka Satoshi , Iinuma Hisae , Wakabayashi Go , Mori Masaki , Sasako Mitsuru , Mimori Koshi
Published: April 2023

XLS file 9K, Characteristics of 8 patients with GC whose BM samples were used for whole transcriptome analysis
Supplementary Figure 1 from In Vivo Fluorescence Lifetime Imaging for Monitoring the Efficacy of the Cancer Treatment
Authors: Ardeshirpour Yasaman , Chernomordik Victor , Hassan Moinuddin , Zielinski Rafal , Capala Jacek , Gandjbakhche Amir
Published: April 2023

PDF file - 1428KB, (a) Normalized fluorescence signal, measured at the tumor site, along with the fitting line, used for lifetime calculations. (b) Results of the convolution simulations to evaluate potential effect of the impulse response function (IRF) of the measurement system in the case of convolution of two exponentially decaying signals with slopes, corresponding to the IRF width and ABD-HER2-Affibody-AlexaFluor750 conjugate.
Supplementary Table S4 from Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer
Authors: Dai Wei , Zeller Constanze , Masrour Nahal , Siddiqui Nadeem , Paul James , Brown Robert
Published: April 2023

Supplementary Table S4 - XLS file 107K, Quality Control
Supplementary Table S3 from Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer
Authors: Dai Wei , Zeller Constanze , Masrour Nahal , Siddiqui Nadeem , Paul James , Brown Robert
Published: April 2023

Supplementary Table S3 - XLS file 72K, Fragment information
Supplementary Figure 3 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
Authors: Ria Roberto , Catacchio Ivana , Berardi Simona , De Luisi Annunziata , Caivano Antonella , Piccoli Claudia , Ruggieri Vitalba , Frassanito Maria Antonia , Ribatti Domenico , Nico Beatrice , Annese Tiziana , Ruggieri Simona , Guarini Attilio , Minoia Carla , Ditonno Paolo , Angelucci Emanuele , Derudas Daniele , Moschetta Michele , Dammacco Franco , Vacca Angelo
Published: April 2023

PDF file - 403K, HIF-1alpha protein negative MMECs are sensitive to the antiangiogenic effect of bortezomib and lenalidomide.
Supplementary Figure 1 from Promoter CpG Island Methylation of Genes in Key Cancer Pathways Associates with Clinical Outcome in High-Grade Serous Ovarian Cancer
Authors: Dai Wei , Zeller Constanze , Masrour Nahal , Siddiqui Nadeem , Paul James , Brown Robert
Published: April 2023

Supplementary Figure 1 - PDF file 32K, Log2 transformed DMH ratios in 100% methylated samples compared to 0% methylated sample
Supplementary Figure 2 from HIF-1α of Bone Marrow Endothelial Cells Implies Relapse and Drug Resistance in Patients with Multiple Myeloma and May Act as a Therapeutic Target
Authors: Ria Roberto , Catacchio Ivana , Berardi Simona , De Luisi Annunziata , Caivano Antonella , Piccoli Claudia , Ruggieri Vitalba , Frassanito Maria Antonia , Ribatti Domenico , Nico Beatrice , Annese Tiziana , Ruggieri Simona , Guarini Attilio , Minoia Carla , Ditonno Paolo , Angelucci Emanuele , Derudas Daniele , Moschetta Michele , Dammacco Franco , Vacca Angelo
Published: April 2023

PDF file - 133K, HIF-1alpha protein correlates with VEGFR-2, FGFR-2 and HGF.
Supplementary Figure 6 from Reciprocal Interactions between Tumor-Associated Macrophages and CD44-Positive Cancer Cells via Osteopontin/CD44 Promote Tumorigenicity in Colorectal Cancer
Authors: Rao Guanhua , Wang Hongyi , Li Baowei , Huang Li , Xue Danfeng , Wang Xiaohui , Jin Haijing , Wang Jun , Zhu Yushan , Lu Youyong , Du Lei , Chen Quan
Published: April 2023

PDF file - 1587K, Kaplan-Meier curves of survival rate for 190 patients.
Supplementary Figure 5 from Reciprocal Interactions between Tumor-Associated Macrophages and CD44-Positive Cancer Cells via Osteopontin/CD44 Promote Tumorigenicity in Colorectal Cancer
Authors: Rao Guanhua , Wang Hongyi , Li Baowei , Huang Li , Xue Danfeng , Wang Xiaohui , Jin Haijing , Wang Jun , Zhu Yushan , Lu Youyong , Du Lei , Chen Quan
Published: April 2023

PDF file - 1119K, A CD44v6 neutralizing antibody blocks the OPN-induced enhanced clonogenicity.
Supplementary Methods from Cidofovir: A Novel Antitumor Agent for Glioblastoma
Authors: Hadaczek Piotr , Ozawa Tomoko , Soroceanu Liliana , Yoshida Yasuyuki , Matlaf Lisa , Singer Eric , Fiallos Estefania , James C. David , Cobbs Charles S.
Published: April 2023

PDF file - 82K, 1) Protein extraction for Western blot and Western blot analysis 2) Cell culture, infection, treatment, and viability assays 3) RNA extraction and real-time PCR 4) Tissue processing and immunohistochemistry 5) Analysis and quantification of staining.
Supplementary Table 4 from Proteome Profiling of Cancer-Associated Fibroblasts Identifies Novel Proinflammatory Signatures and Prognostic Markers for Colorectal Cancer
Authors: Torres Sofia , Bartolomé Rubén A. , Mendes Marta , Barderas Rodrigo , Fernandez-Aceñero M. Jesús , Peláez-García Alberto , Peña Cristina , Lopez-Lucendo María , Villar-Vázquez Roi , de Herreros Antonio García , Bonilla Felix , Casal J. Ignacio
Published: April 2023

XLSX file - 204K, List of proteins differentially-expressed in whole cellular extracts of CAFs with a fold-change >1.4
Supplementary Figure 1 from MET Is a Potential Target across All Papillary Renal Cell Carcinomas: Result from a Large Molecular Study of pRCC with CGH Array and Matching Gene Expression Array
Authors: Albiges Laurence , Guegan Justine , Le Formal Audrey , Verkarre Virginie , Rioux-Leclercq Nathalie , Sibony Mathilde , Bernhard Jean-Christophe , Camparo Philippe , Merabet Zahira , Molinie Vincent , Allory Yves , Orear Cedric , Couvé Sophie , Gad Sophie , Patard Jean-Jacques , Escudier Bernard
Published: April 2023

PDF file - 153KB, Correlation analysis of the expression level of 36 genes - involved in MET pathway - between the patients harboring a MET mutations, the 6 ccRCC samples, and normal kidney tissue samples.
Supplementary Table A2 from Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial
Authors: Tabernero Josep , Garcia-Carbonero Rocio , Cassidy James , Sobrero Alberto , Van Cutsem Eric , Köhne Claus-Henning , Tejpar Sabine , Gladkov Oleg , Davidenko Irina , Salazar Ramon , Vladimirova Liubov , Cheporov Sergey , Burdaeva Olga , Rivera Fernando , Samuel Leslie , Bulavina Irina , Potter Vanessa , Chang Yu-Lin , Lokker Nathalie A. , O'Dwyer Peter J.
Published: April 2023

Overall survival (Kaplan-Meier Method) by PIK3CA and NRAS status
Supplementary Table 1 from PI3K Pathway Activation in High-Grade Ductal Carcinoma In Situ—Implications for Progression to Invasive Breast Carcinoma
Authors: Sakr Rita A. , Weigelt Britta , Chandarlapaty Sarat , Andrade Victor P. , Guerini-Rocco Elena , Giri Dilip , Ng Charlotte K.Y. , Cowell Catherine F. , Rosen Neal , Reis-Filho Jorge S. , King Tari A.
Published: April 2023

PDF file - 23KB, Characteristics of patients with pure high-grade DCIS and high-grade DCIS associated with IBC included in this study.
Supplementary Figure 1 from Plasma MicroRNA Are Disease Response Biomarkers in Classical Hodgkin Lymphoma
Authors: Jones Kimberley , Nourse Jamie P. , Keane Colm , Bhatnagar Atul , Gandhi Maher K.
Published: April 2023

PDF file - 76K, Figure S1. Comparative quantification of circulating miRNA.
Supplementary Table 3 from Unique DNA Methylation Loci Distinguish Anatomic Site and HPV Status in Head and Neck Squamous Cell Carcinoma
Authors: Lleras Roberto A. , Smith Richard V. , Adrien Leslie R. , Schlecht Nicolas F. , Burk Robert D. , Harris Thomas M. , Childs Geoffrey , Prystowsky Michael B. , Belbin Thomas J.
Published: April 2023

PDF file, 982K, List of hypermethylated and hypomethylated CpG loci identified in LXSCC.
Supplementary Figure 3 from BET Bromodomain Inhibition of MYC-Amplified Medulloblastoma
Authors: Bandopadhayay Pratiti , Bergthold Guillaume , Nguyen Brian , Schubert Simone , Gholamin Sharareh , Tang Yujie , Bolin Sara , Schumacher Steven E. , Zeid Rhamy , Masoud Sabran , Yu Furong , Vue Nujsaubnusi , Gibson William J. , Paolella Brenton R. , Mitra Siddhartha S. , Cheshier Samuel H. , Qi Jun , Liu Kun-Wei , Wechsler-Reya Robert , Weiss William A. , Swartling Fredrik J. , Kieran Mark W. , Bradner James E. , Beroukhim Rameen , Cho Yoon-Jae
Published: April 2023

PDF file - 291K, Densitometry quantification of Western Immunoblots shown in Figures 4 and 5.
Supplementary Figure Legend from T Lymphocytes Redirected against the Chondroitin Sulfate Proteoglycan-4 Control the Growth of Multiple Solid Tumors both In Vitro and In Vivo
Authors: Geldres Claudia , Savoldo Barbara , Hoyos Valentina , Caruana Ignazio , Zhang Ming , Yvon Eric , Del Vecchio Michele , Creighton Chad J. , Ittmann Michael , Ferrone Soldano , Dotti Gianpietro
Published: April 2023

PDF file - 68K